18 rectal cancer patients were given the same drug for six months and as a result of the treatment, the cancer was completely obliterated in every patient.
Cancer vanishes from every patient’s body in drug trials “miraculously”; Shocked doctors’ say ‘For the first time in history
During the trial, the patient took Dostarlimab every three weeks for six months. It is noteworthy that they were all in similar stages of their cancer. The cancer was locally advanced in the rectum, but had not spread to other organs.
For the first time, the effectiveness of a womb cancer drug undergoing clinical trial has left everyone shocked.
The drug, Dostarlimab, has seemingly cured every participant in the trial.
The small group of people suffering from rectal cancer witnessed that their cancer vanished after the experimental treatment.
According to reports, the 18 patients in the small clinical trial took Dostarlimab for around six months and after over 12 months the doctors found that their cancer has disappeared.
According to experts, Dostarlimab is a drug with laboratory-produced molecules and it acts as substitute antibodies in the human body.
Reportedly, all 18 rectal cancer patients were given the same drug and as a result of the treatment, the cancer was completely obliterated in every patient. The cancer is undetectable by physical exam; endoscopy; positron emission tomography, PET scans, or MRI scans. Although the sample size of the trial is quite small, it definitely proves that Dostarlimab can be a potential cure for one of the most deadly common cancers.
Dr. Luis A. Diaz, J. Of New York’s Memorial Sloan Kettering Cancer Center said this was “the first time this has happened in the history of cancer”.
Comments